Empowering the Immunocompromised and Elderly: ExeVir Bio presents promising XVR013m data at ID Week 2024
GHENT, Belgium, Oct. 17, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious diseases, is pleased to announce its participation in ID Week 2024, where it will …